Drugs Disributed by Taro International Ltd
: Nucleoside & Guanosine Reverse Transcriptase Inhibitor. Lamivudine 300 mg, Abacavir 600 mg. TABS.:30. The recomm. dosage for adult.& child. over the age of 12 wt. at least 40 kg, is one tab., once dly. See lit.
Indicated in antiretrovir. comb. ther. for the tmt. of (HIV) infect. in adult., adolesc. and child. weigh. at least 25 kg.
Retinoids. Adapalene 1 mg (0.1%), Benzoyl Peroxide 25 mg (2.5%). TOPICAL GEL: 30 g. For extern. use only. Thin layer of gel evenly over acne (pimples) affected areas should be appl. once dly., at bdtme. on a clean dry skin.
Eyes, lips, nostrils contact should be avoid. See lit.
Cutaneous tmt. of acne vulgaris when comedones, papules and pustules are present.
Women who are preg. or suspect. to be preg.
Proteasome Inhibitor. Bortezomib 3.5 mg. VIAL (Pwdr. for sol. for inj.): 1×3.5 mg. Dosage should be ajust. individ. See lit.
Mantle Cell Lymphoma: For the tmt. of pts/ with mantle cell lymphoma who have received at least one prior ther.
Bortezomib in comb. with rituximab, cyclophosphamide, doxorubicin & prednisone is indicated for the tmt. of adult pts. with previous. untreat. mantle cell lymphoma who are unsuitable for haematopoietic stem cell transplantation.
C/I: Hypers. to bortezomib, boron or mannitol. Acute diffuse infiltrative pulmon. and pericard. dis. Intrathecal admin.
Doxorubicin 2mg/ml. VIAL. (Liposome Concentrate for Sol. for IV infus.: 10, 25ml
Dosage must be ajust. individ. according to the pt. indication and tolerability.
1st or 2nd line ther. of AIDS related Kaposis sarcoma in pts. with low CD 4 counts and extensive mucocutaneous or visceral dis.
Tmt. of pts. with metastat. carcinoma of the ovary who are refract.to both paclitaxel and platinium-based chemother. regimens and who may also be refract. to topotecan. Refract. is defined as a pt. having progress. dis.while on tmt. or within 6 mnths. of complet. tmt.
As monother.for pts. with metastat. breast cancer where there is an incr.card. risk.
In comb. with bortezomib for the tmt. of progress. multiplemyeloma in pts. who have received at least one prior ther. and who have already undergone or are unsuit. for bone marrow transplant.
Hypersens. peanut or soya.
Pts. with AIDS-KS that may be effectively treated with local therapy or systemic alfa-interferon.
Antimetabolite (antifolate). Pemetrexed 100, 500, 1000 mg. VIAL(Pwdr.for concent. for sol. for infus.):1. Comb. with cisplatin: 500 mg/m2 of bdy. surface area (BSA) admin. as an IV infus. over 10 min. on the 1st day of each 21-day cycle. The recomm. dose of cisplatin is 75 mg/m2 BSA infused over 2 hrs. approx. 30 min. after complet. of the pemetrexed infus. on the 1st day of each 21-day cycle. Pts. must receive adequate anti-emetic tmt. and appropr. hydration prior to and/or after receiv. cisplatin. Pemetrexed as single agent: In pts. treat. for NSCLC after prior chemother., the recomm. dose of pemetrexed is 500 mg/m2 BSA admin. as an IV infus. over 10 min. on the 1st day of each 21-d. cycle.
For pre-medic. regimen, pt. monitor., & dose ajust.: See lit.
In comb. with cisplatin: for the tmt. of pts. with malig. pleural mesothelioma whose dis. is unresect. or who are otherwise not candidates for curatible surg.
In comb. with cisplatin: 1st line tmt. of pts. with local. advanc. or metastat. non-small cell lung canc. other than predom. squamous cell histology.
As monother. for the 2nd line tmt. of pts. with local. advanc. or metastat. non-small cell lung canc. other than predominant. squamous cell histology.
As monother. for the maintenan. tmt. of locally advance. or metastat. non-small cell lung canc. other than predominant. squamous cell histology in pts. whose dis. has not progress. immediat. follow. platinum-based chemother.
Concomit. use yellow fever vaccine.